| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly
|
Dawson, L.K.
|
|
2000
|
36 |
18 |
p. 2353-2359
7 p.
|
artikel
|
| 2 |
Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil
|
Koyama, F
|
|
2000
|
36 |
18 |
p. 2403-2410
8 p.
|
artikel
|
| 3 |
Antitumour effects of genetically engineered Salmonella in combination with radiation
|
Platt, J
|
|
2000
|
36 |
18 |
p. 2397-2402
6 p.
|
artikel
|
| 4 |
Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women
|
Gershoni-Baruch, R
|
|
2000
|
36 |
18 |
p. 2313-2316
4 p.
|
artikel
|
| 5 |
Combining a name algorithm with a capture–recapture method to retrieve cases of Turkish descent from a German population-based cancer registry
|
Razum, O
|
|
2000
|
36 |
18 |
p. 2380-2384
5 p.
|
artikel
|
| 6 |
Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
|
González-Larriba, J.L
|
|
2000
|
36 |
18 |
p. 2344-2352
9 p.
|
artikel
|
| 7 |
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy
|
Limat, S
|
|
2000
|
36 |
18 |
p. 2360-2367
8 p.
|
artikel
|
| 8 |
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model
|
Hammond, L.A
|
|
2000
|
36 |
18 |
p. 2430-2436
7 p.
|
artikel
|
| 9 |
Epigenetic lesions causing genetic lesions in human cancer
|
Esteller, M
|
|
2000
|
36 |
18 |
p. 2294-2300
7 p.
|
artikel
|
| 10 |
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)±folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients
|
Bensmaı̈ne, M.A
|
|
2000
|
36 |
18 |
p. 2335-2343
9 p.
|
artikel
|
| 11 |
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer
|
Thomas, A.L
|
|
2000
|
36 |
18 |
p. 2329-2334
6 p.
|
artikel
|
| 12 |
Genetic polymorphism in CYP17 and breast cancer risk in Japanese women
|
Miyoshi, Y
|
|
2000
|
36 |
18 |
p. 2375-2379
5 p.
|
artikel
|
| 13 |
Index
|
|
|
2000
|
36 |
18 |
p. IN1-IN47
nvt p.
|
artikel
|
| 14 |
Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin
|
Aben, K.K.H
|
|
2000
|
36 |
18 |
p. 2385-2389
5 p.
|
artikel
|
| 15 |
p53 And related proteins in epithelial ovarian cancer
|
Sengupta, P.S
|
|
2000
|
36 |
18 |
p. 2317-2328
12 p.
|
artikel
|
| 16 |
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
|
Robain, M.
|
|
2000
|
36 |
18 |
p. 2301-2312
12 p.
|
artikel
|
| 17 |
Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC)
|
Oshika, Y
|
|
2000
|
36 |
18 |
p. 2390-2396
7 p.
|
artikel
|
| 18 |
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours
|
van Moorsel, C.J.A
|
|
2000
|
36 |
18 |
p. 2420-2429
10 p.
|
artikel
|
| 19 |
Should specialist breast units be adopted in Europe? A comment from Europe
|
Mansel, R.E.
|
|
2000
|
36 |
18 |
p. 2286-2287
2 p.
|
artikel
|
| 20 |
State-of-the-art breast units — a possibility or a fantasy? A comment from the US
|
Silverstein, M.J
|
|
2000
|
36 |
18 |
p. 2283-2285
3 p.
|
artikel
|
| 21 |
The homeobox gene MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines
|
Jones, T.A.
|
|
2000
|
36 |
18 |
p. 2368-2374
7 p.
|
artikel
|
| 22 |
Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line
|
Formelli, F
|
|
2000
|
36 |
18 |
p. 2411-2419
9 p.
|
artikel
|
| 23 |
The requirements of a specialist breast unit
|
EUSOMA,
|
|
2000
|
36 |
18 |
p. 2288-2293
6 p.
|
artikel
|
Tijdschrift beschrijving